Human induced pluripotent stem cell (iPSC)-based models are a valuable resource for studying disease mechanisms in vitro at the cellular level[1], screening potential new therapeutics[2], and investigating the propensity and mechanism for the development of toxic side effects caused by a drug treatment[3]. Such iPSC-based models enable research to be performed under defined experimental conditions and in a reproducible manner. [Read more…]
Gameto Secures $44M Series C to Advance Fertilo as First iPSC-Derived Reproductive Therapy to Reach Phase 3 in the U.S.
- As birth rates decline and USÂ IVF access falls further behind, Gameto recruits first Phase 3 patients for cutting-edge biotechnology to reignite reproductive health possibilities
- Company’s $127 million in total funding represents one of the largest investment in reproductive US biopharma sector to date
AUSTIN, Texas, Aug. 12, 2025 – Gameto, a clinical-stage biotechnology company developing stem cell-derived therapies for reproductive health, today announced the completion of a $44 million Series C financing round led by Overwater Ventures, with participation from Insight Partners, RA Capital, Two Sigma Ventures, BOLD Capital Partners, Future Ventures, Ingeborg Investments, Arcadia Investment Partners, PAGS Group, Pontiva Healthcare Partners, Portfolia, and additional investors. [Read more…]
What Are Stem Cells Used For
What are stem cells used for? There are many potential uses for stem cells, from the treatment of cancer to chronic conditions, acute injuries and more. Scientists continue to perform research on stem cells to maximize their therapeutic benefits and possible contributions to the medical industry.
In this article:
- Why Are Stem Cells Important?
- What Are Stem Cells Used For in Medicine?
- What Are Stem Cells Used For in the Body?
- Why Are Stem Cells Valuable in Research?
What Are Stem Cells Used For? | Some FAQs Answered
While stem cells are important for treating people with major health issues, they are also advancing new frontiers in healthcare. [Read more…]
iPS Cell Therapy: Is Japan the Market Leader?
Although there are key players in multiple geographies worldwide, Japan has positioned itself as a hub for induced pluripotent stem cell (iPS cell) technology. iPS cells are made by reprogramming adult cells back into an embryonic-like state. Derived from skin or blood cells, they are not controversial.
iPSC Research Expands – 40+ Companies Offer Research Tools to Scientists
Induced pluripotent stem cells (iPSCs) have become a major focus of scientific research, with over 33,000 publications on the topic currently available on PubMed.gov, the world’s leading database for scientific literature. These cells, which are reprogrammed from differentiated somatic cells back to an embryonic-like state, have opened up new possibilities in regenerative medicine, drug development, and disease modeling. Since the groundbreaking discovery of iPSCs in 2006, the field has seen rapid expansion, with an increasing number of research products and technologies entering the market. To fully understand the competitive landscape of iPSC-based innovations, it is crucial to explore the growing presence of competitors and the advancements made in this dynamic space. [Read more…]
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 78
- Next Page »